APP and Alzheimer disease: Dempsey et al. observed the therapeutic effect of MCC950 in APP/PS1 mice and suggested that MCC950 could improve cognitive function and promote Aβ clearance, indicating that the inhibition of the NLRP3 inflammasome was a crucial therapeutic target for AD [80].